Aroa Biosurgery Limited

ASX:ARX Rapporto sulle azioni

Cap. di mercato: AU$219.0m

Aroa Biosurgery Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Brian Ward

Amministratore delegato

NZ$1.1m

Compenso totale

Percentuale dello stipendio del CEO54.1%
Mandato del CEO17.2yrs
Proprietà del CEO9.6%
Durata media del management3.6yrs
Durata media del Consiglio di amministrazione9.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

We're Not Worried About Aroa Biosurgery's (ASX:ARX) Cash Burn

Nov 13
We're Not Worried About Aroa Biosurgery's (ASX:ARX) Cash Burn

Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Aug 22
Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Jun 12
Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Mar 25
Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Jan 30
Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Nov 14
Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Nov 02
Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

Oct 25
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

May 13
We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

May 26
Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Mar 22
An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Feb 24
Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Feb 24
Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

Dec 16
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Brian Ward rispetto agli utili di Aroa Biosurgery?
DataCompenso totaleStipendioGuadagni aziendali
Mar 31 2024NZ$1mNZ$583k

-NZ$11m

Dec 31 2023n/an/a

-NZ$9m

Sep 30 2023n/an/a

-NZ$8m

Jun 30 2023n/an/a

-NZ$4m

Mar 31 2023NZ$1mNZ$552k

-NZ$396k

Dec 31 2022n/an/a

-NZ$1m

Sep 30 2022n/an/a

-NZ$2m

Jun 30 2022n/an/a

-NZ$5m

Mar 31 2022NZ$1mNZ$542k

-NZ$8m

Dec 31 2021n/an/a

-NZ$10m

Sep 30 2021n/an/a

-NZ$11m

Jun 30 2021n/an/a

-NZ$15m

Mar 31 2021NZ$2mNZ$483k

-NZ$19m

Compensazione vs Mercato: La retribuzione totale di Brian ($USD 633.03K ) è superiore alla media delle aziende di dimensioni simili nel mercato Australian ($USD 298.50K ).

Compensazione vs guadagni: La retribuzione di Brian è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Brian Ward

17.2yrs

Mandato

NZ$1,078,619

Compensazione

Dr. Brian Ward, B.V.Sc, MBA(dist) has been Executive Director at Aroa Biosurgery Limited since September 21, 2007 and serves as its Managing Director and Chief Executive Officer. He has founded Aroa Biosur...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Brian Ward
Founderno dataNZ$1.08m9.6%
A$ 21.0m
James Agnew
CFO & Joint Company Secretary4.8yrsNZ$627.01kNessun dato
Rod Stanley
Chief Technology Officerless than a yearNessun datoNessun dato
Barnaby May
Chief Scientific Officer2.9yrsNessun dato0.95%
A$ 2.1m
Neetha Alex-Kumar
General Counselno dataNessun datoNessun dato
Frazer Murray
Director of Global Marketing & Strategyno dataNessun datoNessun dato
Yasmin Winchester
Vice President of Qualityno dataNessun datoNessun dato
Tracy Weimar
Joint Company Secretary4.3yrsNessun datoNessun dato
Adam Young
Vice President of Medical Affairsno dataNessun datoNessun dato

3.6yrs

Durata media

Gestione esperta: Il team dirigenziale di ARX è considerato esperto (durata media dell'incarico 3.6 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Brian Ward
Founder17.2yrsNZ$1.08m9.6%
A$ 21.0m
James McLean
Independent Non-Executive Chairperson13.3yrsNZ$212.19k0.82%
A$ 1.8m
John Diddams
Independent Non-Executive Director5yrsNZ$159.36k0.35%
A$ 757.3k
John Pinion
Independent Non-Executive Director9.8yrsNZ$187.52k0.14%
A$ 300.0k
Philip McCaw
Non-Executive Director16.7yrsNZ$130.68k5.68%
A$ 12.4m
Catherine Mohr
Independent Non-Executive Director2yrsNZ$178.02k0.13%
A$ 277.1k
Darla Hutton
Independent Non-Executive Directorless than a yearNZ$4.73k0.041%
A$ 89.0k

9.8yrs

Durata media

58yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ARX sono considerati esperti (durata media dell'incarico 9.8 anni).